Key Insights Given the large stake in the stock by institutions, OmniAb's stock price might be vulnerable to their...
EMERYVILLE, Calif., June 03, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced the publication of a peer-reviewed paper titled "Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies" in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies.
Key Insights Using the 2 Stage Free Cash Flow to Equity, OmniAb fair value estimate is US$6.77 Current share price of...